Establishment of an interleukin‐5‐dependent subclone from an interleukin‐3‐dependent murine hemopoietic progenitor cell line, LyD9, and its malignant transformation by autocrine secretion of interleukin‐5.
Kaoru Tohyama(Kawasaki Medical School), Tasuku Honjo(Kyoto University), Tatsuo Kinashi(Kansai Medical University), KK Lee(Chungbuk National University), Kei Tashiro(Kyoto Prefectural University of Medicine)
Cited by 24
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
|Immunity|1999|2.7k